相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Rapid generation of CD19 CAR-T cells by minicircle DNA enables anti-tumor activity and prevents fatal CAR-B leukemia
Xueshuai Ye et al.
CANCER LETTERS (2023)
CD8+T cell exhaustion and cancer immunotherapy
Qingda Wang et al.
CANCER LETTERS (2023)
Engaging stemness improves cancer immunotherapy
Hassan Dianat-Moghadam et al.
CANCER LETTERS (2023)
Cancer-associated fibroblasts: Key criminals of tumor pre-metastatic niche
Guozhang Dong et al.
CANCER LETTERS (2023)
Hypoxia induces immunosuppression, metastasis and drug resistance in pancreatic cancers
Huan Zhang et al.
CANCER LETTERS (2023)
IKZF3 deficiency potentiates chimeric antigen receptor T cells targeting solid tumors
Yan Zou et al.
CANCER LETTERS (2022)
Giant obscurin regulates migration and metastasis via RhoA-dependent cytoskeletal remodeling in pancreatic cancer
Soontorn Tuntithavornwat et al.
CANCER LETTERS (2022)
Remodeling metabolic fitness: Strategies for improving the efficacy of chimeric antigen receptor T cell therapy
Luyan Shen et al.
CANCER LETTERS (2022)
Tumor-derived extracellular vesicles induce invalid cytokine release and exhaustion of CD19 CAR-T Cells
Xiaoying Zhu et al.
CANCER LETTERS (2022)
Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer
Rom Leidner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer
Sanaz Taromi et al.
CANCER LETTERS (2022)
Therapeutic bispecific antibodies against intracellular tumor antigens
Guanghui Xu et al.
CANCER LETTERS (2022)
Activation of STING in the pancreatic tumor microenvironment: A novel therapeutic opportunity
Hanane Chamma et al.
CANCER LETTERS (2022)
Single cell RNA-seq reveals the CCL5/SDC1 receptor-ligand interaction between T cells and tumor cells in pancreatic cancer
Kai Chen et al.
CANCER LETTERS (2022)
Neoantigen-targeted TCR-T cell therapy for solid tumors: How far from clinical application
Ruihan Xu et al.
CANCER LETTERS (2022)
The trilogy of P21 activated kinase, autophagy and immune evasion in pancreatic ductal adenocarcinoma
Yi Ma et al.
CANCER LETTERS (2022)
Direct identification of HLA class I and class II-restricted T cell epitopes in pancreatic cancer tissues by mass spectrometry
Kenji Fujiwara et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
CAR T cells in solid tumors: challenges and opportunities
Faroogh Marofi et al.
STEM CELL RESEARCH & THERAPY (2021)
TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers
Nisha B. Nagarsheth et al.
NATURE MEDICINE (2021)
Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-mediated mechanism
Mengwen Zhang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma
Jennifer N. Brudno et al.
NATURE MEDICINE (2020)
Autophagy regulation as a promising approach for improving cancer immunotherapy
Nestor Ishimwe et al.
CANCER LETTERS (2020)
Anti-EGFR chimeric antigen receptor-modified T cells in metastatic pancreatic carcinoma: A phase I clinical trial
Yang Liu et al.
CYTOTHERAPY (2020)
Engineering CAR-T Cells for Next-Generation Cancer Therapy
Mihe Hong et al.
CANCER CELL (2020)
Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers
Andrew R. Haas et al.
MOLECULAR THERAPY (2019)
Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers
Kaichao Feng et al.
PROTEIN & CELL (2018)
Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial
Gregory L. Beatty et al.
GASTROENTEROLOGY (2018)
Therapeutic developments in pancreatic cancer: current and future perspectives
John P. Neoptolemos et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1c259 T Cells in Synovial Sarcoma
Sandra P. D'Angelo et al.
CANCER DISCOVERY (2018)
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
Yao Wang et al.
ONCOIMMUNOLOGY (2018)
Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase
Alec J. Walker et al.
MOLECULAR THERAPY (2017)
CD19 CAR-T cells of defined CD4+: CD8+ composition in adult B cell ALL patients
Cameron J. Turtle et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps
Gregory L. Beatty et al.
PHARMACOLOGY & THERAPEUTICS (2016)
T Cell Antigen Receptor Recognition of Antigen-Presenting Molecules
Jamie Rossjohn et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer
D. Korbakis et al.
BRITISH JOURNAL OF CANCER (2015)
T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma
Ingunn M. Stromnes et al.
CANCER CELL (2015)
LAMC2 enhances the metastatic potential of lung adenocarcinoma
Y. W. Moon et al.
CELL DEATH AND DIFFERENTIATION (2015)
Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6
Lindsey M. Draper et al.
CLINICAL CANCER RESEARCH (2015)
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee et al.
LANCET (2015)
Laminin-5γ-2 (LAMC2) Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Progression, Migration, and Invasion by Modulating Signaling of EGFR
Manoj Garg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Marco L. Davila et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
Gregory L. Beatty et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Laminin, gamma 2 (LAMC2): A Promising New Putative Pancreatic Cancer Biomarker Identified by Proteomic Analysis of Pancreatic Adenocarcinoma Tissues
Hari Kosanam et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
Paul F. Robbins et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette
Matthias Leisegang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability
Cyrille J. Cohen et al.
CANCER RESEARCH (2006)
How the T cell receptor sees antigen - A structural view
KC Garcia et al.
CELL (2005)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)